3458 results

First report of outcomes in the TRILUMINATE pivotal clinical trial in patients with severe tricuspid regurgitation

21 Sep 2022

Alex Sticchi provides his take on the TRILUMINATE pivotal trial which was presented by David H. Adams at the TCT Congress 2022.

Author

Alessandro Sticchi

OPTIMUM: Outcomes of Percutaneous RevascularizaTIon for Management of SUrgically Ineligible Patients with Multivessel or Left Main Coronary Artery Disease

04 Nov 2021

Mirvat Alasnag reviews the OPTIMUM trial, presented by David E. Kandzari, which reports outcomes in a subset of patients who are increasingly seen in modern day catheterization laboratories. It is noteworthy that 1 in 5 patients with left main or multivessel disease are considered surgically ineligible.

Author

Mirvat Alasnag

Femoral artery pseudoaneurysm expansion managed through subcutaneous fat embolization

06 Apr 2021

Femoral artery pseudoaneurysm is a known complication following cardiac catheterization. Rarely, expansion of the pseudoaneurysm can occur and is often catastrophic. We describe a unique method employed by our centre to deal with such a complication.

Author

Raja Ezman Raja

PCR London Valves 2019 – Three new focussed Educational Pathways

Prepare your 3-day itinerary using a filter option on the online Programme: transseptal access for mitral valve procedures, bicuspid aortic valve, and electrosurgery (BASILICA/transcaval)

40 years of Angioplasty at the Opening Ceremony

Watch the video presented at the Opening Ceremony in front of a crowded Main Arena: emotion guaranteed!

Applied learnings

Discover the Applied learnings, a set of case-based sessions and LIVE demonstrations designed for experienced physicians wishing to improve their Peripheral expertise.

First half of DK-Crush technique for bailout stenting of a true 0,0,1 bifurcation

09 Dec 2022

Stent implantation is largely debated in true 0,0,1 bifurcation lesion. This case shows bailout IVUS-guided stenting of a large diagonal branch after DEB-induced dissection, performed by employing the first half of the DK-Crush technique, thus avoiding stenting in the disease-free left anterior descending artery.

Author

Giuseppe Andó

Author

Marco Borgi

Author

Giulia Alagna

FAME 3: A Randomized Trial of FFR-Guided Stenting Compared With CABG

12 Nov 2021

Examination of the study methodology and results according to the PICOT principle, SWOT analysis and real-world applicability of the FAME 3 trial presented at TCT 2021.

Spotlight on a selection of top Late-breaking Trials presented at PCR London Valves 2025

17 Nov 2025

View a snapshot of the results of these 4 trials in valvular and structural interventions presented in London during this year's Heart Team Course!

ASSURE DES - Perioperative antiplatelet therapy in patients with coronary stents before non-cardiac surgery

31 Aug 2024

Elad Asher provides his take on the ASSURE DES trial presented by Jung-Min Ahn at the ESC Congress 2024 in London.

Author

Elad Asher

RIPCORD 2: does routine pressure wire assessment influence management strategy of coronary angiography for diagnosis of chest pain?

29 Aug 2021

Nicola Ryan presents a synthesis of this study which compares FFR-guided assessment of patients with chest pain with angiographic guidance alone, and which was presented by Nicholas Curzen (Southampton, USA) during the ESC Congress 2021.

Author

Nicola Ryan

COVID-19: safety and efficacy of the mRNA-1273 SARSCoV-2 vaccine (Moderna) against SARS-CoV-2

22 Jan 2021

Examination of the study methodology and results according to the PICOT principle, SWOT analysis and real-world applicability

CoreValve™ and Evolut™ TAVI systems

13 May 2022

Sponsored by Medtronic

Portico with FlexNav TAVI late breaking data and sessions from the PCR e-Course 2020

25 Jun 2020

Learn about the Portico with FlexNav TAVI system and its deliverability and how it enables you to achieve favourable hemodynamics and optimal patient outcomes, while preserving coronary access.

Primary left ventricular unloading in anterior STEMI without cardiogenic shock: Results from the STEMI-Door to Unload randomized clinical trial

28 Mar 2026

Elad Asher provides his take on the STEMI-DTU trial, which was presented by Navin K. Kapur at the ACC.26 in New Orleans, and simultaneously published in the JACC.

Author

Elad Asher

MERIL announces successful primary outcomes of next-gen Myval THV series in major RCT, presented at EuroPCR 2024 - Earns prestigious late Breaking trial status & The LANCET acceptance.

15 May 2024

Effective techniques for performing DCB angioplasty

16 Jan 2025

Drug-coated balloon (DCB) angioplasty has become a valuable alternative to drug-eluting stents in treating coronary artery disease. To achieve optimal outcomes, proper lesion preparation and techniques to minimise drug loss are crucial.

This article highlights key steps and best practices for performing DCB angioplasty, ensuring effective drug delivery and...

Author

Valeria Paradies

Author

Gianluca Mincione

The JenaValve Trilogy™ heart valve system in high surgical risk patients with symptomatic, severe aortic regurgitation: The ALIGN AR Trial

25 Oct 2023

Nicola Ryan provides her take on the ALIGN AR trial which was presented by Vinod H. Thourani at TCT Congress 2023. The Align AR trial is a prospective single-arm investigation device exemption study assessing the safety and efficacy of the Trilogy transcatheter heart valve system in patients with...

Author

Nicola Ryan

BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial

07 Nov 2022

Nicola Ryan provides her take on the BRIGHT-4 study, which was presented during AHA 2022 in Chicago, & simultaneously published in the Lancet.

This study was a randomised control trial designed to assess if bivalirudin plus a high dose infusion for 2-4 hours post PPCI was superior to unfractionated...

Author

Nicola Ryan

Shockwave Medical study confirms benefit of IVL-first strategy in real-world female patients with complex calcified lesions in late-breaking data presentation at EuroPCR 2025

20 May 2025